ANTI-CERAMIT-ANTIKÖRPER

European patent · EP3177650 · In force

Register entry

Publication number
EP3177650
Application number
EP15830378
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 7, 2015
Published
Jun 14, 2017
Granted
Nov 5, 2025
Protection ends at the latest
Aug 6, 2035
Next annual fee due
Aug 31, 2026
IPC classes
C07K 16/28 (2006.01)
A61K 39/395 (2006.01)
Priority
US 201462034453 P 07.08.2014
PCT application
PCT/US2015/044144 07.08.2015
PCT publication
WO2016/022883 11.02.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 16, 2026

    Change

    Published in Swissreg on 16.09.2026

  2. Nov 5, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 05.11.2025

Parties

Holder

Memorial Sloan-Kettering Cancer Center

Office of Technology Development 1275 York Avenue Box 524, New York, NY 10065, US

Ceramide Therapeutics

760 Parkside Avenue Room 209, Brooklyn, NY 11226, US

Inventor

ROTOLO, Jimmy

Port Washington, NY 11050, US

KOLESNICK, Richard

New York City, NY 10022, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.